Cell viability was monitored by MTT assay. A2780, A2780/DDP, SKOV3, and SKOV3/DDP cells were seeded in 96-well plates 24 hours prior to treatment. Cells were then treated with different doses (0, 5, 10, 20, 40, and 80 μM) of cisplatin for 24 hours. A total of 20 μL MTT was added into each well and incubated for 4 hours at 37°C. One hundred fifty microliters of dimethyl sulfoxide was then added into each well to resolve MTT formazan crystals. Absorbance was measured at a wavelength of 490 nm using Model 680 micro-plate reader (Bio-Rad Laboratories, Hercules, CA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.